9 November 2004
NEW YORK. Nexense, an emerging sensing technology company,
has created a generic biosensor platform which offers direct, contact-free
monitoring of vital signs, including heart and respiration rate, in a
passive, non-intrusive and non-radiating manner.
The biosensor platform is based on Nexense's patented method of measuring
parameters, such as temperature, acceleration, pressure, distance, weight
and any other physical entities. Measurements are made in a direct digital
manner and not constrained by the limitations of traditional sensor
"The biosensor's accuracy and sensitivity far surpass
anything available on the market today, even when compared to hospital-based
professional patient monitoring systems," said Asialee Huang, senior vice
president, corporate strategies and worldwide business development, Nexense.
"As a result, it's easy to see the potential for developing innovative
physiological monitoring applications and improving on existing patient
monitors and current diagnostic imaging systems based on this platform."
This generic platform can be adapted and integrated into
many existing medical imaging systems to enhance performance. For example,
Nexense is currently collaborating with a leading medical company to develop
a triggering device for MRI and CT, based on Nexense's generic technology
platform, which will enable real-time 3D images of any organ in a
non-invasive and non-intrusive way and without the risks associated with a
Nexense is also working with Fujitsu on the development of
an ASIC chip for non-intrusive monitoring and tracking of vital signs via
mobile phones. The company expects the technology to be available in early
2005. Additionally, the biosensor will be the platform for the company's
Nexaver(TM) line of non-intrusive, vital signs monitors. These products
non-intrusively monitor vital signs from under a mattress, and require no
wiring or contact with the user.
This biosensor platform can be applied to a variety of
other industries outside of the healthcare sector. In automotive, the
technology is being used to develop seat occupancy detection for smart air
bag deployment. It can also be used to notify parents of a child left alone
in a vehicle or alert a tired driver. Similar applications can be developed
for aviation. In security, monitoring cargo containers or creating high
sensitivity intrusion detection systems can be developed.
"The miniscule size, extreme accuracy, and low power
consumption of our biosensor makes embedding it into new and existing
electronics easy," added Huang. "This gives Nexense the ability to provide
solutions to our partner companies, from simple to extremely complex, within
a quick-to-market time frame and higher profitability opportunities.
For more information see www.nexense.com